Ticovac 2.4MCG/0.5 10S
Ended Awarded
- Contract number
- SPE2DR26FBTAQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,135
Award facts
- Contract value 100% obligated
- $2,134.57 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,134.57 firm fixed-price delivery order (4570007403) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for TICOVAC 2.4MCG/0.5 10S vaccine product. The award, finalized on November 14, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V initiative, a $30.3 billion governmentwide acquisition strategy designed to provide streamlined access to a comprehensive range of pharmaceutical products and medical consumables.
The underlying Pharmaceutical Prime Vendor Global Program Generation V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. Under this prime vendor arrangement, the Defense Logistics Agency is authorized to issue delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support worldwide military healthcare operations. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBTAQ?
SPE2DR26FBTAQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FBTAQ worth?
The government has obligated $2,135 on SPE2DR26FBTAQ.
Is contract SPE2DR26FBTAQ an order under another contract?
Yes. SPE2DR26FBTAQ is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTAQ competed?
The extent of competition for SPE2DR26FBTAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award